340 related articles for article (PubMed ID: 22908173)
1. 2-[4,5-Difluoro-2-(2-fluorobenzoylamino)-benzoylamino]benzoic acid, an antiviral compound with activity against acyclovir-resistant isolates of herpes simplex virus types 1 and 2.
Strand M; Islam K; Edlund K; Oberg CT; Allard A; Bergström T; Mei YF; Elofsson M; Wadell G
Antimicrob Agents Chemother; 2012 Nov; 56(11):5735-43. PubMed ID: 22908173
[TBL] [Abstract][Full Text] [Related]
2. Frequency of acyclovir-resistant herpes simplex viruses isolated from the general immunocompetent population and patients with acquired immunodeficiency syndrome.
Ziyaeyan M; Alborzi A; Japoni A; Kadivar M; Davarpanah MA; Pourabbas B; Abassian A
Int J Dermatol; 2007 Dec; 46(12):1263-6. PubMed ID: 18173520
[TBL] [Abstract][Full Text] [Related]
3. Cytopathic effect inhibition assay for determining the in-vitro susceptibility of herpes simplex virus to antiviral agents.
Cotarelo M; Catalán P; Sánchez-Carrillo C; Menasalvas A; Cercenado E; Tenorio A; Bouza E
J Antimicrob Chemother; 1999 Nov; 44(5):705-8. PubMed ID: 10552991
[TBL] [Abstract][Full Text] [Related]
4. Phenotypic testing of patient herpes simplex virus type 1 and 2 isolates for acyclovir resistance by a novel method based on real-time cell analysis.
Caliaro O; Barbani MT; Klenja S; Morfin F; Frobert E; Gorgievski M; Steinlin-Schopfer J; Suter-Riniker F
J Clin Virol; 2020 Apr; 125():104303. PubMed ID: 32163870
[TBL] [Abstract][Full Text] [Related]
5. Phenotypic and genotypic characterization of acyclovir-resistant herpes simplex viruses from immunocompromised patients.
Gaudreau A; Hill E; Balfour HH; Erice A; Boivin G
J Infect Dis; 1998 Aug; 178(2):297-303. PubMed ID: 9697707
[TBL] [Abstract][Full Text] [Related]
6. Resistance of herpes simplex viruses to nucleoside analogues: mechanisms, prevalence, and management.
Piret J; Boivin G
Antimicrob Agents Chemother; 2011 Feb; 55(2):459-72. PubMed ID: 21078929
[TBL] [Abstract][Full Text] [Related]
7. Association of the Emergence of Acyclovir-Resistant Herpes Simplex Virus Type 1 With Prognosis in Hematopoietic Stem Cell Transplantation Patients.
Kakiuchi S; Tsuji M; Nishimura H; Yoshikawa T; Wang L; Takayama-Ito M; Kinoshita H; Lim CK; Fujii H; Yamada S; Harada S; Oka A; Mizuguchi M; Taniguchi S; Saijo M
J Infect Dis; 2017 Mar; 215(6):865-873. PubMed ID: 28453848
[TBL] [Abstract][Full Text] [Related]
8. CMX001 potentiates the efficacy of acyclovir in herpes simplex virus infections.
Prichard MN; Kern ER; Hartline CB; Lanier ER; Quenelle DC
Antimicrob Agents Chemother; 2011 Oct; 55(10):4728-34. PubMed ID: 21788472
[TBL] [Abstract][Full Text] [Related]
9. Herpes simplex virus resistance to acyclovir: clinical relevance.
Pottage JC; Kessler HA
Infect Agents Dis; 1995 Sep; 4(3):115-24. PubMed ID: 8548189
[TBL] [Abstract][Full Text] [Related]
10. In vitro and in vivo antiherpetic effects of (1R,2R)-1-(5'-methylful-3'-yl)propane-1,2,3-triol.
Sasaki K; Hayashi K; Matsuya Y; Sugimoto K; Lee JB; Kurosaki F; Hayashi T
J Nat Med; 2016 Apr; 70(2):217-24. PubMed ID: 26763002
[TBL] [Abstract][Full Text] [Related]
11. Natural history of neonatal herpes simplex virus infections in the acyclovir era.
Kimberlin DW; Lin CY; Jacobs RF; Powell DA; Frenkel LM; Gruber WC; Rathore M; Bradley JS; Diaz PS; Kumar M; Arvin AM; Gutierrez K; Shelton M; Weiner LB; Sleasman JW; de Sierra TM; Soong SJ; Kiell J; Lakeman FD; Whitley RJ;
Pediatrics; 2001 Aug; 108(2):223-9. PubMed ID: 11483781
[TBL] [Abstract][Full Text] [Related]
12. The Anti-Human Immunodeficiency Virus Drug Tenofovir, a Reverse Transcriptase Inhibitor, Also Targets the Herpes Simplex Virus DNA Polymerase.
Andrei G; Gillemot S; Topalis D; Snoeck R
J Infect Dis; 2018 Feb; 217(5):790-801. PubMed ID: 29186456
[TBL] [Abstract][Full Text] [Related]
13. Herpes Simplex Virus Type 1 Clinical Isolates Respond to UL29-Targeted siRNA Swarm Treatment Independent of Their Acyclovir Sensitivity.
Kalke K; Lehtinen J; Gnjatovic J; Lund LM; Nyman MC; Paavilainen H; Orpana J; Lasanen T; Frejborg F; Levanova AA; Vuorinen T; Poranen MM; Hukkanen V
Viruses; 2020 Dec; 12(12):. PubMed ID: 33322225
[TBL] [Abstract][Full Text] [Related]
14. HSV susceptibility to acyclovir - genotypic and phenotypic characterization.
Vikas R; Prabhu SG; Mudgal PP; Shetty U; Karunakaran K; Jagadesh A; Auti A; Stansilaus RP; Nair S; Arunkumar G
Antivir Ther; 2019; 24(2):141-145. PubMed ID: 30507553
[TBL] [Abstract][Full Text] [Related]
15. Virucidal effect of peppermint oil on the enveloped viruses herpes simplex virus type 1 and type 2 in vitro.
Schuhmacher A; Reichling J; Schnitzler P
Phytomedicine; 2003; 10(6-7):504-10. PubMed ID: 13678235
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of Cafon gel on cutaneous infection with herpes simplex virus (HSV)-2 and acyclovir-resistant HSV in mice.
Yoshida Y; Yamamura J; Sato H; Koyasu M; Obara Y; Sekiguchi H; Kawana T; Shiraki K
J Dermatol Sci; 1996 Dec; 13(3):237-41. PubMed ID: 9023706
[TBL] [Abstract][Full Text] [Related]
17. Effective deploying of a novel DHODH inhibitor against herpes simplex type 1 and type 2 replication.
Luganini A; Sibille G; Mognetti B; Sainas S; Pippione AC; Giorgis M; Boschi D; Lolli ML; Gribaudo G
Antiviral Res; 2021 May; 189():105057. PubMed ID: 33716051
[TBL] [Abstract][Full Text] [Related]
18. Potentiated virucidal activity of pomegranate rind extract (PRE) and punicalagin against Herpes simplex virus (HSV) when co-administered with zinc (II) ions, and antiviral activity of PRE against HSV and aciclovir-resistant HSV.
Houston DMJ; Bugert JJ; Denyer SP; Heard CM
PLoS One; 2017; 12(6):e0179291. PubMed ID: 28665969
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of Intrathecal Acyclovir Resistant Virus in Herpes Simplex Encephalitis Patients.
Mitterreiter JG; Titulaer MJ; van Nierop GP; van Kampen JJ; Aron GI; Osterhaus AD; Verjans GM; Ouwendijk WJ
PLoS One; 2016; 11(5):e0155531. PubMed ID: 27171421
[TBL] [Abstract][Full Text] [Related]
20. Genotypic and phenotypic characterization of acyclovir-resistant herpes simplex viruses isolated from haematopoietic stem cell transplant recipients.
Stránská R; van Loon AM; Polman M; Beersma MF; Bredius RG; Lankester AC; Meijer E; Schuurman R
Antivir Ther; 2004 Aug; 9(4):565-75. PubMed ID: 15456088
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
